Lashanda Skerritt awarded Vanier Canada Graduate Scholarship
“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC...
Research suggests greater access to specific HIV and tuberculosis medications is needed worldwide
Postdoctoral fellows at the RI-MUHC carried out primary statistical analyses for study published in The Lancet
Inappropriate prescriptions sending hospitalized seniors back to the ER
Improving hospital prescribing practices may reduce risk of rehospitalization and death
Canada Research Chairs Program announces new and renewed chairs
Congratulations to five RI-MUHC researchers in the spring 2020 round!
With Veterans Affairs Canada, Dr. Steven Grover and his team are getting Canadian families moving
The summer Family Fitness Mission
Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients
Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine
Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli
A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics
Three COVID-19 projects at the RI-MUHC to receive CIHR funding
A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease
COVID-19 pandemic: Looking back to better tackle future challenges
In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies
Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper
A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis